Psychemedics Microplate Eia for Amphetamine
Enzyme Immunoassay, Amphetamine. 510(k) K130811, from Psychemedics Corp. (Culver City, CA). Product code DKZ, class 2.
As of Nov 22, 2026, K130811 is an FDA 510(k) held by Psychemedics Corp., substantially equivalent on May 2, 2013 after 38 days, with no recalls tied to it in FDA's recall database.
- Review time: 38 days
- Recalls: 0
- Cited as a predicate by: 1 device
The Psychemedics Microplate EIA for Amphetamine is an enzyme immunoassay (EIA) for the preliminary qualitative detection of amphetamine in human head and body hair using an amphetamine calibrator at 3 ng /10 mg hair cutoff for the purpose of identifying amphetamine use. This is an in vitro diagnostic device intended exclusively for Psychemedics use only.
- Cozart Eia Amphetamines Oral Fluid Microplate KitK033743 · Cozart Bioscience , Ltd. · Jun 3, 2004
- Psychemedics Homogeneous Enzyme Immunoassay for Amphetamines in HairK210212 · Psychemedics Corporation · Dec 15, 2021
- DRI Ecstasy Plus AssayK240670 · Microgenics Corporation · Oct 30, 2024
- AllTest Multi-Drug Rapid Test Cup; AllTest Multi-Drug Rapid Test Panel; AllTest Multi-Drug Rapid Test Cup Rx; AllTest…K233019 · Hangzhou AllTest Biotech Co., Ltd. · Dec 13, 2023
- Xenta Drug Screen Cup, Xenta Drug Screen DipcardK231137 · Xenta Biomedical Science Co., Ltd. · May 19, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Mar 25, 2013
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3100
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files